$XBI $93.50 | -1.08%
Covid Updates
$NVAX -6.2% Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine source
$SRNE +1.9% Sorrento Announces Completion of Enrollment in US Phase 2 Clinical Trial for COVI-DROPS and Achievement of Interim Analysis Threshold in the UK. source
Pipeline Updates
$MRKR -2.7% MARKER THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR ITS MULTI-ANTIGEN TARGETED T CELL THERAPY FOR PANCREATIC CANCER source
$LMNL -1.8% Liminal BioSciences Announces Strategic Priorities For 2022 source
$VYNE -4.2% VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis. source
$CCXI -3.9% ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis. source
$AKTX +4.2% FDA Agrees to Use of New Higher-Yielding Manufacturing Process for Nomacopan in Pivotal Clinical Studies. source
$SPRO -1.9% Spero Therapeutics Awarded up to an Additional $12.9 Million by BARDA to Support the Development of Orally Administered Tebipenem Pivoxil in Pediatric Patients. source
$CTMX +6.5% CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for the Treatment of Advanced Solid Tumors. source
$GMDA +22.5% Gamida Cell Provides Update on Omidubicel BLA Submission. source
$HCM -2.7% HUTCHMED Highlights Fruquintinib Clinical Data to be Presented at the 2022 ASCO Gastrointestinal Cancers Symposium. source
Business Updates
$EVFM +22.9% Evofem Biosciences Announces Record Net Sales and Phexxi Prescriptions in Q4 2021. source
$ADMA +3.7%ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update. source
$OSMT -0.9% Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance. source
Posted by FS/JM
Comentários